Overnight' Success's Cost? 25 Years – Propanc Biopharma CEO’s 25 Year Grind | Seth Farbman’s Podcast

What if cancer could be turned from a killer into a manageable chronic illness with no hair loss, no nausea, and no immunosuppression? In this gripping episode of Startup to Stock Exchange, host Seth Farbman goes deep with James Nathanielsz, CEO of NASDAQ-listed Propanc Biopharma (PPCB). From a 17-year grind raising over $30M, battling economic crashes, COVID, and regulatory wars, to compassionate-use stories where terminal patients defied odds and lived years longer, James reveals the science behind their novel proenzyme therapy PRP. Now NASDAQ-uplisted and gearing up for a landmark Phase 1b first-in-human trial in 2026 targeting advanced solid tumors like pancreatic and ovarian cancers, this could redefine treatment in massive markets. A raw, no-BS conversation on biotech perseverance, integrity in public markets, patient hope, and a potential game-changer that started with one doctor's desperate fight to save lives. Don't miss the underdog story that might just change everything.Seth’s CompaniesVstock Transfer – https://www.vstocktransfer.com/Share Media – https://www.sharemedia.co/Listen to the ShowApple Podcasts – https://podcasts.apple.com/us/podcast/seth-farbman-on-podcast-from-startup-to-stock-exchange/id1356667808Spotify – https://open.spotify.com/show/54i7xkWaAALAFrUvk4WZcNConnect with SethLinkedIn – https://www.linkedin.com/in/sethfarbman/Instagram – https://www.instagram.com/sethfarbmanstockTikTok – https://www.tiktok.com/@sethfarbmanTwitter (X) – https://x.com/sethfarbman1About the ShowFrom Startup to Stock Exchange, hosted by entrepreneur and investor Seth Farbman, spotlights the journey of founders and CEOs as they scale their companies from early ideas to public markets. Each episode features candid conversations with leaders across industries, offering insights on growth, fundraising, branding, and the mindset it takes to build a company that lasts.00:48 – Seth introduces James Nathanielsz & Propanc Biopharma (PPCB)02:13 – Rambo scars analogy: 17+ years of entrepreneurial wars03:08 – Propanc today: 17 years, $30M raised, NASDAQ uplist 202503:55 – Seth on the insane conviction needed for 17-year biotech grind08:12 – Core motivation: helping families, belief the drug truly works10:37 – Origin: 28-year-old mom gained 2 extra years via treatment12:34 – 46 compassionate patients: 19 terminal cases beat huge odds, no side effects15:26 – Vision: Turn metastatic cancer into a chronic illness game-changing17:23 – “25 years of overnight success” 32:50 – Get treatment to patients fast, transformative potentialConnect with Seth LinkedIn – https://www.linkedin.com/in/sethfarbman/ Instagram – https://www.instagram.com/sethfarbmanstock TikTok – https://www.tiktok.com/@sethfarbman Twitter (X) – https://x.com/sethfarbman1